Guest

Paul M Ridker MD
Eugene Braunwald Professor of Medicine
Harvard Medical School
Director, Center for Cardiovascular Disease Prevention
Brigham and Women's Hospital, Boston, MA
Boston, MA

Dr Ridker reports having received research funding support from multiple not-for-profit entities including the National Heart, Lung, and Blood Institute, the National Cancer Institute, the American Heart Association, the Doris Duke Charitable Foundation, the Leducq Foundation, the Donald W Reynolds Foundation, and the James and Polly Annenberg La Vea Charitable Trusts. Dr Ridker also reports having received investigator-initiated research support from AstraZeneca and Novartis, as well as nonfinancial research support from Amgen. Dr Ridker is listed as a coinventor on patents held by the Brigham and Women's Hospital that relate to the use of inflammatory biomarkers in cardiovascular disease that have been licensed to Siemens and AstraZeneca and has served as a research consultant to Merck, Isis, Vascular Biogenics, Amylin, and Genzyme.